Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

92 Parkinson’s Trials Are Terminated

Trial Name Last Updated
Genetics of Motor Learning 11/08/2018
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153) 11/06/2018
Central Mechanisms in Speech Motor Control Studied With H215O PET 11/05/2018
Evaluation of Primary Chronic Autonomic Failure 11/01/2018
Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease 10/08/2018
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes 10/05/2018
A Study of Movement Disorders Using the QMAT At-Home Testing Device 09/25/2018
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT 09/06/2018
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease 08/27/2018
Videofluoroscopic Swallowing Study (VFSS) 08/23/2018
Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease 08/14/2018
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients. 06/20/2018
tDCS in Parkinson's Disease With Depression 05/14/2018
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease 05/11/2018
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo 05/03/2018
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease 03/30/2018
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia 03/29/2018
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). 03/26/2018
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease 03/05/2018
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations 02/26/2018
DNS-7801 vs. Placebo in Parkinson's Disease 02/01/2018
Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients 01/08/2018

Page 1 of 5 pages  1 2 3 >  Last ›

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).